NeoGenomics Inc. Common Stock vs W.R. Berkley Corporation Common Stock — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.14B), while W.R. Berkley Corporation Common Stock trades at $74.93 (market cap $27.30B). The key difference: W.R. Berkley Corporation Common Stock is far larger — about 12.8× NeoGenomics Inc. Common Stock's market cap, and W.R. Berkley Corporation Common Stock pays a 0.54% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and W.R. Berkley Corporation Common Stock for 0 Days on average.
| NEO | WRB | |
|---|---|---|
Market Cap | $2.14B | $27.30B |
Volume | 2,228,400 | 2,293,079 |
Sector | Health | Financials |
52-Week High | $19.91 | $78.10 |
52-Week Low | $7.19 | $63.54 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.44B | $27.54B |
Dividend Yield | — | 0.54% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →W.R. Berkley Corporation is an insurance holding company that underwrites commercial property and casualty insurance and reinsurance through its Insurance and Reinsurance & Monoline Excess segments.
Read more on WRB →